AURO-CEFTAZIDIME ceftazidime (as pentahydrate) 1g powder for injection vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

ceftazidime pentahydrate, Quantity: 1175 mg (Equivalent: ceftazidime, Qty 1000 mg)

Disponible depuis:

Strides Pharma Science Pty Ltd

DCI (Dénomination commune internationale):

ceftazidime pentahydrate

forme pharmaceutique:

Injection, powder for

Composition:

Excipient Ingredients: sodium carbonate

Mode d'administration:

Intravenous

Unités en paquet:

5 vials, 1 vial

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

AURO-CEFTAZIDIME is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime; as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other antipseudomonal antibiotics cannot be used. . Indications include the following.. Severe infections in general. For example: septicaemia (including neonatal sepsis), bacteraemia; in patients in intensive care units with specific problems, e.g. infected burns.. Respiratory tract. For example: pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis.. Severe ear, nose and throat infections. For example: otitis media, mastoiditis.. Urinary tract. For example: acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only); infections associated with bladder and renal stones.. Skin and soft tissue. . For example: erysipelas, abscesses, cellulitis, infected burns and wounds, mastitis.. Gastrointestinal and abdominal. . For example: intra-abdominal abscesses, enterocolitis.. Bone and joint. . For example: osteitis, osteomyelitis, septic arthritis, infected bursitis.

Descriptif du produit:

Visual Identification: White or cream coloured powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Registered

Date de l'autorisation:

2010-10-19